Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.smspharma.com | |
Market Cap | 1,004.82 Cr. | |
Enterprise Value(EV) | 1,245.82 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 3.67 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 32.36 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.59 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 56.58 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 2.10 | Calculated using Price: 118.70 |
Dividend Yield | 0.25 | Period Ending 2023-03 |
No. of Shares Subscribed | 8.47 Cr. | 84,652,030 Shares |
FaceValue | 1 | |
About SMS Pharmaceuticals Ltd. | ||
SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base. Having six multi product facilities in operation, one under development, and two research centers, SMS has truly graduated in to big league with more than 600 employees working for it. |
1 Day |
|
-0.17% |
1 Week |
|
-0.63% |
1 Month |
|
-1.33% |
3 Month |
|
-6.81% |
6 Month |
|
+27.93% |
1 Year |
|
+39.67% |
2 Year |
|
-6.85% |
5 Year |
|
+87.33% |
10 Year |
|
+656.88% |
9 years | 2007-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 14.11 | 17.57 | 12.99 | 15.00 | 13.67 | 9.76 | 16.07 | 15.41 | 0.83 | |
Return on Capital Employed (%) | 18.91 | 19.54 | 12.73 | 18.17 | 16.57 | 13.06 | 17.62 | 12.60 | 3.79 | |
Return on Assets (%) | 7.73 | 8.46 | 6.15 | 7.95 | 7.62 | 5.50 | 8.44 | 7.97 | 0.44 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 294 | 255 | 284 | 322 | 348 | 411 | 470 | 461 | 479 | |
Non Curr. Liab. | 162 | 91 | 97 | 94 | 114 | 206 | 193 | 164 | 157 | |
Curr. Liab. | 200 | 156 | 134 | 156 | 154 | 211 | 211 | 255 | 341 | |
Minority Int. | ||||||||||
Equity & Liab. | 656 | 502 | 515 | 572 | 617 | 828 | 875 | 880 | 977 | |
Non Curr. Assets | 408 | 336 | 334 | 351 | 389 | 503 | 482 | 469 | 477 | |
Curr. Assets | 248 | 166 | 181 | 221 | 228 | 325 | 392 | 411 | 500 | |
Misc. Exp. not W/O | ||||||||||
Total Assets | 656 | 502 | 515 | 572 | 617 | 828 | 875 | 880 | 977 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 612 | 445 | 465 | 465 | 412 | 563 | 520 | 522 | 600 | |
Other Income | 4 | 1 | 2 | 3 | 5 | 3 | 5 | 5 | 5 | |
Total Income | 615 | 447 | 467 | 468 | 417 | 567 | 525 | 527 | 605 | |
Total Expenditure | -522 | -370 | -372 | -375 | -332 | -442 | -405 | -467 | -504 | |
PBIDT | 93 | 77 | 96 | 94 | 85 | 125 | 120 | 59 | 101 | |
Interest | -17 | -16 | -15 | -12 | -12 | -11 | -19 | -22 | -24 | |
Depreciation | -19 | -19 | -20 | -19 | -22 | -22 | -32 | -32 | -32 | |
Taxation | -15 | -6 | -20 | -21 | -18 | -30 | -1 | -1 | -11 | |
Exceptional Items | ||||||||||
PAT | 42 | 36 | 40 | 41 | 33 | 61 | 68 | 4 | 34 | |
Minority Interest | ||||||||||
Share Associate | -1 | -7 | -9 | -1 | -1 | 2 | -6 | -11 | -3 | |
Other Related Items | ||||||||||
Consolidated Net Profit | 41 | 28 | 32 | 40 | 32 | 63 | 62 | -7 | 31 | |
Adjusted EPS | 5 | 3 | 4 | 5 | 4 | 7 | 7 | -1 | 4 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 61 | 73 | 32 | 50 | 40 | 90 | 45 | 22 | |
Cash Fr. Inv. | -97 | -39 | -17 | -35 | -43 | -152 | -27 | -30 | |
Cash Fr. Finan. | 44 | -33 | -15 | -13 | -2 | 92 | -12 | -32 | |
Net Change | 9 | 1 | 0 | 2 | -5 | 31 | 6 | -39 | |
Cash & Cash Eqvt | 11 | 12 | 13 | 15 | 10 | 40 | 47 | 7 |
Sat, 18 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome Transcript of the Conference Call held on 10th November 2023. |
Thu, 16 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vistra ITCL (India) Ltd |
Wed, 15 Nov 2023
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 14 2023 for Hima Bindu Potluri |
Wed, 06 Dec 2023 |
|
|
|
|
|